Giancaspro v. Novartis Pharmaceuticals Corporation
Jeffrey Giancaspro |
Novartis Pharmaceuticals Corporation |
6:2021cv01312 |
August 13, 2021 |
US District Court for the Middle District of Florida |
David A Baker |
Roy B Dalton |
Gregory J Kelly |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. § 1332 |
Both |
Docket Report
This docket was last retrieved on September 24, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 40 NOTICE of Appearance by Melanie H. Muhlstock on behalf of Jeffrey Giancaspro (Muhlstock, Melanie) |
Filing 39 NOTICE of Appearance by Harrison Macy Biggs on behalf of Jeffrey Giancaspro (Biggs, Harrison) |
Filing 38 BRIEF on Case Status in Giancaspro by Novartis Pharmaceuticals Corporation. (Johnston, Robert) Modified text on 9/15/2021 (TNP). |
Filing 37 Member Case BRIEF by Jeffrey Giancaspro. (Silverman, Raymond) Modified text on 9/15/2021 (TNP). |
Filing 36 NOTICE of Appearance by Raymond C. Silverman on behalf of Jeffrey Giancaspro (Silverman, Raymond) |
Filing 35 NOTICE of Appearance by Christopher Carl Oxx on behalf of Jeffrey Giancaspro (Oxx, Christopher) |
Filing 34 NOTICE of Appearance by Joe Gregory Hollingsworth on behalf of Novartis Pharmaceuticals Corporation (Hollingsworth, Joe) |
Filing 33 NOTICE of Appearance by Robert E. Johnston on behalf of Novartis Pharmaceuticals Corporation (Johnston, Robert) |
Filing 32 NOTICE of Appearance by Grant Hollingsworth on behalf of Novartis Pharmaceuticals Corporation (Hollingsworth, Grant) |
Filing 31 NOTICE of Appearance by Andrew L. Reissaus on behalf of Novartis Pharmaceuticals Corporation (Reissaus, Andrew) |
Filing 30 PRETRIAL ORDER NO. 1. Status Conference set for 9/28/2021 at 10:00 AM in Orlando Courtroom 4 A before Judge Roy B. Dalton, Jr. All motions pending as of the date of this Order are DENIED WITHOUT PREJUDICE. Parties seeking relief should renew any motions by refiling them in the individual member cases or in the lead case as appropriate. Signed by Judge Roy B. Dalton, Jr. on 8/31/2021. Associated Cases: 6:21-md-03006-RBD-DAB et al.(BIA) (Additional attachment(s) added on 9/1/2021: #1 Exhibit A) (BIA). |
Filing 29 Case Reassigned to Magistrate Judge David A Baker per Order at Doc. 2 in case 6:21-md-3006-RBD-DAB. New case number: 6:21-cv-01312-RBD-DAB. Magistrate Judge Gregory J. Kelly no longer assigned to the case. (ALL) |
Filing 28 MULTIDISTRICT LITIGATION member case. Master MDL case number: 3006 Receipt of original record from the Middle District of Florida, case number: 3:20-cv-00346-BJD-MCR. Assigned MDFL case number: 6:21-cv-01312-RBD-GJK. (ALL) |
Filing 27 Case transferred in from District of Florida Middle; Case Number 3:20-cv-00346. File received electronically |
Filing 26 MULTIDISTRICT LITIGATION panel order transferring case to: Orlando Division. Assigned case number: 6:21-md-3006-RBD-GJK. MDL case number: 3006 (SJW) [Transferred from flmd on 8/13/2021.] |
Filing 25 ENDORSED ORDER: #23 Plaintiff's Motion to Stay is DENIED. Signed by Judge Brian J. Davis on 7/12/2021. (AMP) [Transferred from flmd on 8/13/2021.] |
Filing 24 MEMORANDUM in opposition re #23 Motion to Stay filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit 1)(Thomas, Michael) [Transferred from flmd on 8/13/2021.] |
Filing 23 MOTION to Stay by Jeffrey Giancaspro. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Albites, Francisco) [Transferred from flmd on 8/13/2021.] |
Filing 22 ENDORSED ORDER granting #21 Joint Motion to Extend Mediation Deadline. The mediation deadline is extended to November 22, 2021. All other terms and deadlines in #14 Case Management and Scheduling Order shall remain intact. Signed by Magistrate Judge Monte C. Richardson on 5/21/2021. (DLC) [Transferred from flmd on 8/13/2021.] |
Filing 21 Joint MOTION to Modify #14 Case Management / FLSA / ADA / Social Security / Scheduling Order TO EXTEND MEDIATION DEADLINE by Jeffrey Giancaspro. (Albites, Francisco) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.] |
Filing 20 ORDER appointing Dominic M. Caparello, Esq. as mediator in this action. Signed by Judge Brian J. Davis on 8/6/2020. (CKS) [Transferred from flmd on 8/13/2021.] |
Filing 19 NOTICE OF SELECTION of Dominic Caparello as mediator by Novartis Pharmaceuticals Corporation. (Thomas, Michael) [Transferred from flmd on 8/13/2021.] |
Filing 18 CERTIFICATE of interested persons and corporate disclosure statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) [Transferred from flmd on 8/13/2021.] |
Filing 17 CERTIFICATE of interested persons and corporate disclosure statement re #14 Case management and scheduling order by Jeffrey Giancaspro. (Albites, Francisco) [Transferred from flmd on 8/13/2021.] |
Filing 16 NOTICE of compliance re 12 Order on Motion to Appear Pro Hac Vice by Jeffrey Giancaspro (Albites, Francisco) [Transferred from flmd on 8/13/2021.] |
Filing 15 CASE REFERRED to Mediation. (AEJ) [Transferred from flmd on 8/13/2021.] |
Filing 14 CASE MANAGEMENT AND SCHEDULING ORDER: Mediator selection due by 8/4/2020; Conduct mediation hearing by 5/21/2021; Discovery due by 4/15/2022; Dispositive motions due by 4/15/2022; Pretrial statement due by 9/14/2022; Final Pretrial Conference set for 9/21/2022 at 10:00 AM in Jacksonville Courtroom 12 C before Judge Brian J. Davis; Jury Trial set for trial term commencing on 10/3/2022 at 9:00 AM in Jacksonville Courtroom 12 C before Judge Brian J. Davis. Signed by Judge Brian J. Davis on 6/16/2020. (Attachments: #1 Mediation Report Form, #2 Docket Sheets)(AMP) [Transferred from flmd on 8/13/2021.] |
Filing 13 CASE MANAGEMENT REPORT. (Attachments: #1 Exhibit Confidentiality Agreement, #2 Exhibit Proposed Order)(Albites, Francisco) [Transferred from flmd on 8/13/2021.] |
Filing 12 ENDORSED ORDER granting #8 Motion to Appear Pro Hac Vice; granting #9 Motion to Appear Pro Hac Vice; granting #10 Motion to Appear Pro Hac Vice; granting #11 Motion to Appear Pro Hac Vice. If Attorneys Silverman, Reissaus, McMinn, and Johnston have not already done so, they shall immediately register for a login and password for electronic filing at the Court's website at www.flmd.uscourts.gov. Signed by Magistrate Judge Monte C. Richardson on 6/5/2020. (MM) [Transferred from flmd on 8/13/2021.] |
Filing 11 MOTION for Robert E. Johnston to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16891696 for $150 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Affidavit Special Admission Certificate)(Thomas, Michael) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.] |
Filing 10 MOTION for Donald R. McMinn to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16891677 for $150 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Affidavit Special Admission Certificate)(Thomas, Michael) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.] |
Filing 9 MOTION for Andrew L. Reissaus to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16891611 for $150 by Novartis Pharmaceuticals Corporation. (Attachments: #1 Affidavit Special Admission Certificate)(Thomas, Michael) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.] |
Filing 8 MOTION for Raymond C. Silverman to appear pro hac vice, Special Admission fee paid, Receipt No. 113A-16886928 for $150 by Jeffrey Giancaspro. (Albites, Francisco) Motions referred to Magistrate Judge Monte C. Richardson. [Transferred from flmd on 8/13/2021.] |
Filing 7 CERTIFICATE of interested persons and corporate disclosure statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) [Transferred from flmd on 8/13/2021.] |
Filing 6 CORPORATE Disclosure Statement by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis Finance Corporation, a New York corporation, Corporate Parent Novartis Corporation, a New York corporation, Corporate Parent Novartis Holding, AG, a Swiss company, Corporate Parent Novartis AG, a Swiss Company, whose American Depository Shares are publicly traded on the New York Stock Exchange for Novartis Pharmaceuticals Corporation.. (Thomas, Michael) [Transferred from flmd on 8/13/2021.] |
Filing 5 ANSWER and affirmative defenses to #1 Complaint with Jury Demand by Novartis Pharmaceuticals Corporation.(Thomas, Michael) [Transferred from flmd on 8/13/2021.] |
Filing 4 NOTICE of designation under Local Rule 3.05 - track 2. Signed by Deputy Clerk on 4/15/2020. (Attachments: #1 Case Management Report Form, #2 Consent Letter and Form)(CKS) [Transferred from flmd on 8/13/2021.] |
Filing 3 SUMMONS issued as to Novartis Pharmaceuticals Corporation. (AEJ) [Transferred from flmd on 8/13/2021.] |
Filing 2 NEW CASE ASSIGNED to Judge Brian J. Davis and Magistrate Judge Monte C. Richardson. New case number: 3:20-cv-346-J-39MCR. (SJB) [Transferred from flmd on 8/13/2021.] |
Filing 1 COMPLAINT against Novartis Pharmaceuticals Corporation with Jury Demand (Filing fee $ 400 receipt number 113A-16670425) filed by Jeffrey Giancaspro. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons)(Albites, Francisco) [Transferred from flmd on 8/13/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Middle District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.